• Polyethyleneimine-Laminarin Nanoparticles Enhance Vaccine Ef

  2026-06-02

  This study introduces cationic laminarin nanoparticles modified with polyethyleneimine (PEI) as an innovative adjuvant platform, showing robust enhancement of both humoral and cellular immune responses to the model antigen ovalbumin. The findings highlight the importance of polysaccharide functionalization for the rational design of nanovaccines and demonstrate improved antigen uptake and dendritic cell activation compared to conventional adjuvants.

• BUB1/KIF14 Complex Drives Chromosome Instability in Thyroid

  2026-06-02

  This study demonstrates that the BUB1/KIF14 complex promotes anaplastic thyroid carcinoma (ATC) progression by inducing chromosome instability (CIN) via phosphorylation of KIF14 at Ser1292. The findings clarify mechanisms of tumor aggressiveness in ATC and highlight potential avenues for targeted intervention.

• MOG (35-55) Peptide: Mechanistic Insights for Autoimmune Enc

  2026-06-01

  Explore the advanced immunological mechanisms and practical optimization strategies of the MOG (35-55) myelin oligodendrocyte glycoprotein peptide for autoimmune encephalomyelitis research. This article uniquely bridges molecular signaling, assay design, and translational impact for multiple sclerosis studies.

• Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor In

  2026-06-01

  Wang et al. (2018) delineate the entry mechanism of genotype III grass carp reovirus (GCRV104), demonstrating that clathrin-mediated, dynamin- and pH-dependent endocytosis is essential for viral infection of CIK cells. Their systematic pharmacological inhibitor analysis clarifies endocytic pathway involvement, offering a robust framework for aquatic virology experiments and informing antiviral strategy development.

• Pam3CSK4: A Synthetic TLR1/2 Agonist for Immune Activation M

  2026-05-31

  Pam3CSK4 is a synthetic TLR1/2 agonist that induces precise immune cell activation and modulates inflammatory responses. This article details its mechanism, evidentiary benchmarks, and application boundaries for translational research in allergy and neuro-immune modulation.

• Moxidectin: Macrocyclic Lactone Anthelmintic in Antifungal S

  2026-05-30

  Moxidectin is redefining macrocyclic lactone anthelmintic applications by potentiating polyene antifungal effects against Candida albicans. This article details advanced experimental workflows, protocol optimizations, and troubleshooting strategies for translational researchers leveraging APExBIO’s high-purity Moxidectin in both parasitic worm control and antifungal innovation.

• Angiotensin II: Protocol Guidance for Vascular Research

  2026-05-29

  Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) enables precise modeling of hypertension, vascular remodeling, and vascular smooth muscle cell hypertrophy in both in vitro and in vivo systems. This peptide is best suited for studies requiring controlled activation of angiotensin receptors and downstream GPCR signaling. It should not be used for diagnostic or therapeutic applications, nor where long-term solution stability is required without validated re-testing.

• Propranolol: Enhancing Experimental Precision in Research

  2026-05-29

  Propranolol, a non-selective β-adrenergic receptor blocker, empowers researchers with reproducible cardiovascular, neurobehavioral, and metabolic modulation across in vitro and in vivo models. Discover protocol enhancements, practical troubleshooting, and comparative advantages using APExBIO’s high-purity Propranolol (SKU BA1217) in your experimental workflows.

• Dual-Action Airway Stent Suppresses Tracheal Restenosis via

  2026-05-28

  Zhao et al. (2025) present a novel airway stent integrating anti-inflammatory and anti-angiogenic functionalities, targeting tracheal in-stent restenosis. This approach employs combined drug-eluting and antimicrobial properties to address excessive vascularization and inflammation, demonstrating significant efficacy in preclinical models and offering new directions for airway implant design.

• Catalpol Modulates SIRT1/HIF-1α to Mitigate Triptolide Hepat

  2026-05-28

  This study reveals that catalpol protects against triptolide-induced liver injury by activating SIRT1, which reduces HIF-1α acetylation and restores energy metabolism. These findings highlight a new mechanism for managing drug-induced hepatic dysfunction, with implications for refining experimental models of oxidative stress and metabolic disease.

• Anisomycin: Driving JNK Pathway Innovation in Translational

  2026-05-27

  This thought-leadership article explores the mechanistic underpinnings and strategic applications of Anisomycin (SKU B6674) as a potent JNK agonist, emphasizing its unique role in apoptosis research, cancer biology, and emerging neurobiology. By connecting experimental insights with translational imperatives, we provide actionable guidance for researchers seeking to harness JNK pathway activation in diverse cellular contexts. Drawing on recent advances in memory maintenance and apoptosis induction, and expanding beyond typical product-centric discussions, this article positions Anisomycin as a catalyst for innovation in both established and next-generation workflows.

• Position 3 Modifications in GnRH Antagonists: Synthesis and

  2026-05-27

  This article analyzes the synthesis and biological evaluation of degarelix analogs modified at position 3 with 3-(2-methoxy-5-pyridyl)-alanine, as reported in Samant et al. The study's rigorous comparison of diastereomeric peptide analogs highlights the potential and challenges of unnatural amino acid incorporation for optimizing GnRH antagonist function and pharmacokinetics.

• Moxidectin Potentiates Polyene Antifungals via Ergosterol Up

  2026-05-26

  The 2024 reference study reveals that moxidectin, a macrocyclic lactone anthelmintic, enhances the antifungal action of polyenes against Candida albicans by upregulating ergosterol biosynthesis. This mechanistic insight suggests a novel approach to overcoming drug resistance in oral candidiasis and may inform future antifungal combination therapies.

• Moxidectin: Mechanism, Evidence, and Cross-Domain Anthelmint

  2026-05-26

  Moxidectin, a macrocyclic lactone anthelmintic, controls veterinary and human parasitic worm infections and demonstrates unique antifungal synergy by upregulating ergosterol biosynthesis in Candida albicans. Its persistent efficacy in animals and new translational roles in antifungal research are well-supported by recent peer-reviewed evidence.

• Cyclic di-GMP: Protocols and Troubleshooting for Biofilm & I

  2026-05-25

  Cyclic di-GMP is reshaping both bacterial biofilm research and mammalian immune modulation, serving as an actionable bridge between microbiology and immunotherapy. This article delivers stepwise protocols, experimental decision points, and troubleshooting tips that maximize the impact of APExBIO’s high-purity cyclic di-GMP for advanced translational workflows.

451 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page